337 related articles for article (PubMed ID: 11167865)
1. Somatostatin and octreotide in the prevention of postoperative pancreatic complications and the treatment of enterocutaneous pancreatic fistulas: a systematic review of randomized controlled trials.
Li-Ling J; Irving M
Br J Surg; 2001 Feb; 88(2):190-9. PubMed ID: 11167865
[TBL] [Abstract][Full Text] [Related]
2. Systematic review and meta-analysis of somatostatin analogues in the prevention of postoperative complication after pancreaticoduodenectomy.
Jin K; Zhou H; Zhang J; Wang W; Sun Y; Ruan C; Hu Z; Wang Y
Dig Surg; 2015; 32(3):196-207. PubMed ID: 25872003
[TBL] [Abstract][Full Text] [Related]
3. Somatostatin analogues for pancreatic surgery.
Gurusamy KS; Koti R; Fusai G; Davidson BR
Cochrane Database Syst Rev; 2012 Jun; (6):CD008370. PubMed ID: 22696379
[TBL] [Abstract][Full Text] [Related]
4. Somatostatin analogues for pancreatic surgery.
Gurusamy KS; Koti R; Fusai G; Davidson BR
Cochrane Database Syst Rev; 2013 Apr; 2013(4):CD008370. PubMed ID: 23633353
[TBL] [Abstract][Full Text] [Related]
5. Meta-analysis of randomized controlled trials on the effectiveness of somatostatin analogues for pancreatic surgery: a Cochrane review.
Koti RS; Gurusamy KS; Fusai G; Davidson BR
HPB (Oxford); 2010 Apr; 12(3):155-65. PubMed ID: 20590882
[TBL] [Abstract][Full Text] [Related]
6. Octreotide and postoperative pancreatic fistula after pancreaticoduodenectomy: What we know so far? A narrative review.
Tilak M; Tewari M; Shukla HS
Indian J Cancer; 2023; 60(2):152-159. PubMed ID: 37530235
[TBL] [Abstract][Full Text] [Related]
7. Cost-effectiveness comparison of prophylactic octreotide and pasireotide for prevention of fistula after pancreatic surgery.
Welsch T; Müssle B; Distler M; Knoth H; Weitz J; Häckl D
Langenbecks Arch Surg; 2016 Nov; 401(7):1027-1035. PubMed ID: 27233242
[TBL] [Abstract][Full Text] [Related]
8. Is octreotide a new hope for enterocutaneous and external pancreatic fistulas closure?
Martineau P; Shwed JA; Denis R
Am J Surg; 1996 Oct; 172(4):386-95. PubMed ID: 8873537
[TBL] [Abstract][Full Text] [Related]
9. Economic evaluation of the use of octreotide for prevention of complications following pancreatic resection.
Rosenberg L; MacNeil P; Turcotte L
J Gastrointest Surg; 1999; 3(3):225-32. PubMed ID: 10481115
[TBL] [Abstract][Full Text] [Related]
10. Efficacy of somatostatin and its analogues in prevention of postoperative complications after pancreaticoduodenectomy: a meta-analysis of randomized controlled trials.
Zeng Q; Zhang Q; Han S; Yu Z; Zheng M; Zhou M; Bai J; Jin R
Pancreas; 2008 Jan; 36(1):18-25. PubMed ID: 18192875
[TBL] [Abstract][Full Text] [Related]
11. [Evaluation of somatostatin or octreotide efficacy in the treatment of external pancreatic fistulas].
Brunaud L; Sebbag H; Marchal F; Verdier A; Bresler L; Tortuyaux JM; Boissel P
Ann Chir; 2001 Feb; 126(1):34-41. PubMed ID: 11255969
[TBL] [Abstract][Full Text] [Related]
12. Somatostatin versus octreotide in the treatment of patients with gastrointestinal and pancreatic fistulas.
Leandros E; Antonakis PT; Albanopoulos K; Dervenis C; Konstadoulakis MM
Can J Gastroenterol; 2004 May; 18(5):303-6. PubMed ID: 15152279
[TBL] [Abstract][Full Text] [Related]
13. Clinical evaluation of somatostatin use in pancreatic resections: Clinical efficacy or limited benefit?
Anderson RJ; Dunki-Jacobs E; Callender GG; Burnett N; Scoggins CR; McMasters KM; Martin RC
Surgery; 2013 Oct; 154(4):755-60; discussion 760. PubMed ID: 24074412
[TBL] [Abstract][Full Text] [Related]
14. Systematic review and meta-analysis of somatostatin analogues for the treatment of pancreatic fistula.
Gans SL; van Westreenen HL; Kiewiet JJ; Rauws EA; Gouma DJ; Boermeester MA
Br J Surg; 2012 Jun; 99(6):754-60. PubMed ID: 22430616
[TBL] [Abstract][Full Text] [Related]
15. Somatostatin analogues for the treatment of enterocutaneous fistulas: a systematic review and meta-analysis.
Coughlin S; Roth L; Lurati G; Faulhaber M
World J Surg; 2012 May; 36(5):1016-1029. PubMed ID: 22419412
[TBL] [Abstract][Full Text] [Related]
16. Somatostatin for the prevention of complications following pancreatoduodenectomy.
Gouillat C
Digestion; 1999; 60 Suppl 3():59-63. PubMed ID: 10567790
[TBL] [Abstract][Full Text] [Related]
17. Are somatostatin or its synthetic analogues helpful in reducing pancreatic fistula?
Angst E; Gloor B
Dig Surg; 2012; 29(6):492-3. PubMed ID: 23392316
[No Abstract] [Full Text] [Related]
18. Nutrition and enterocutaneous fistulas.
Makhdoom ZA; Komar MJ; Still CD
J Clin Gastroenterol; 2000 Oct; 31(3):195-204. PubMed ID: 11033997
[TBL] [Abstract][Full Text] [Related]
19. [Prospective and randomized study on the usefulness of octreotide in the prevention of complications after cephalic duodeno-pancreatectomy].
Briceño Delgado FJ; López Cillero P; Rufián Peña S; Solórzano Peck G; Miño Fugarolas G; Pera Madrazo C
Rev Esp Enferm Dig; 1998 Oct; 90(10):687-94. PubMed ID: 9824933
[TBL] [Abstract][Full Text] [Related]
20. Use of octreotide for the prevention of pancreatic fistula after elective pancreatic surgery: a systematic review and meta-analysis.
Alghamdi AA; Jawas AM; Hart RS
Can J Surg; 2007 Dec; 50(6):459-66. PubMed ID: 18053374
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
